April 20, 2024
Stocks & Bonds
[STOCK WATCH] KDPharm falls 1.31%
[THE INVESTOR] As of Apr. 27 10:10 A.M., KDPharm declined 1.31%, compared with yesterday, to 18,800 won. It had declined 1.05% through the past month. Standard deviation, the volatility index for stock price, was 1% on the same period of time over one month.
Compared with its close competitors within the same industry, KOSDAQ, even though the monthly earnings rate of KDPharm stayed negative, its volatility for 1 month was at the lowest level. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -1.0%. As the volatility was low, the return-on-risk was a proper rate in spite of stock price decline. However, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, 3.3, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
Compared with its close competitors within the same industry, KOSDAQ, even though the monthly earnings rate of KDPharm stayed negative, its volatility for 1 month was at the lowest level. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -1.0%. As the volatility was low, the return-on-risk was a proper rate in spite of stock price decline. However, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, 3.3, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
